Roux-en-Y gastric bypass: effects on feeding behavior and underlying mechanisms
Sean Manning, Andrea Pucci, Rachel L. Batterham
Sean Manning, Andrea Pucci, Rachel L. Batterham
View: Text | PDF
Review Series

Roux-en-Y gastric bypass: effects on feeding behavior and underlying mechanisms

Abstract

Bariatric surgery is the most effective treatment for severe obesity, producing marked sustained weight loss with associated reduced morbidity and mortality. Roux-en-Y gastric bypass surgery (RYGBP), the most commonly performed procedure, was initially viewed as a hybrid restrictive-malabsorptive procedure. However, over the last decade, it has become apparent that alternative physiologic mechanisms underlie its beneficial effects. RYGBP-induced altered feeding behavior, including reduced appetite and changes in taste/food preferences, is now recognized as a key driver of the sustained postoperative weight loss. The brain ultimately determines feeding behavior, and here we review the mechanisms by which RYGBP may affect central appetite-regulating pathways.

Authors

Sean Manning, Andrea Pucci, Rachel L. Batterham

×

Figure 2

Schematic diagram illustrating the anatomy of RYGBP and the mechanisms leading to altered food intake.

Options: View larger image (or click on image) Download as PowerPoint
Schematic diagram illustrating the anatomy of RYGBP and the mechanisms l...
In RYGBP, nutrients rapidly pass through the small gastric pouch, bypassing the majority of the stomach and upper small bowel and directly entering the mid-jejunum. Nutrients meet pancreatic enzymes and bile acids at the common channel only. The anatomic modifications of RYGBP result in a higher secretion of PYY and GLP-1, and these hormonal changes are considered among the main mechanisms responsible for the altered food intake observed in RYGBP patients. Other proposed mechanisms include changes in gut microbiota, altered secretion of bile acids, and altered vagal nerve signaling. Since neural circuits ultimately determine feeding behavior, central effects on brain energy homeostatic centers are likely a final common pathway for each of these RYGBP effector mechanisms. MC4R, expressed on the basolateral membrane of L cells, may have an important role in augmenting RYGBP effects on PYY and GLP-1 secretion.